Ballantyne CM - Search Results

1

Markers of inflammation and their clinical significance.

Ballantyne CM, Nambi V. Ballantyne CM, et al. Atheroscler Suppl. 2005 May;6(2):21-9. doi: 10.1016/j.atherosclerosissup.2005.02.005. Atheroscler Suppl. 2005. PMID: 15823493 Review.

2

ASCOT-LLA and the primary prevention of coronary artery disease in hypertensive patients.

Nambi V, Ballantyne CM. Nambi V, et al. Among authors: ballantyne cm. Curr Atheroscler Rep. 2004 Sep;6(5):353-8. doi: 10.1007/s11883-004-0046-1. Curr Atheroscler Rep. 2004. PMID: 15296701 Review.

3

Utility of statin therapy using high-sensitivity C-reactive protein as an indicator of coronary heart disease risk.

Nambi V, Ballantyne CM. Nambi V, et al. Among authors: ballantyne cm. Curr Atheroscler Rep. 2005 Feb;7(1):22-8. doi: 10.1007/s11883-005-0071-8. Curr Atheroscler Rep. 2005. PMID: 15683598 Review.

4

Lipoprotein-associated phospholipase A2: pathogenic mechanisms and clinical utility for predicting cardiovascular events.

Nambi V, Ballantyne CM. Nambi V, et al. Among authors: ballantyne cm. Curr Atheroscler Rep. 2006 Sep;8(5):374-81. doi: 10.1007/s11883-006-0034-8. Curr Atheroscler Rep. 2006. PMID: 16901407 Review.

5

Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study.

Nambi V, Hoogeveen RC, Chambless L, Hu Y, Bang H, Coresh J, Ni H, Boerwinkle E, Mosley T, Sharrett R, Folsom AR, Ballantyne CM. Nambi V, et al. Among authors: ballantyne cm. Stroke. 2009 Feb;40(2):376-81. doi: 10.1161/STROKEAHA.107.513259. Epub 2008 Dec 18. Stroke. 2009. PMID: 19095974 Free PMC article.

6

Peripheral arterial occlusive disease: magnetic resonance imaging and the role of aggressive medical management.

Lumsden AB, Rice TW, Chen C, Zhou W, Lin PH, Bray P, Morrisett J, Nambi V, Ballantyne C. Lumsden AB, et al. World J Surg. 2007 Apr;31(4):695-704. doi: 10.1007/s00268-006-0732-y. World J Surg. 2007. PMID: 17345122 Review.

7

Combination therapy with statins and omega-3 fatty acids.

Nambi V, Ballantyne CM. Nambi V, et al. Among authors: ballantyne cm. Am J Cardiol. 2006 Aug 21;98(4A):34i-38i. doi: 10.1016/j.amjcard.2005.12.025. Epub 2006 May 30. Am J Cardiol. 2006. PMID: 16919515 Review.

8

Role of biomarkers in developing new therapies for vascular disease.

Nambi V, Ballantyne CM. Nambi V, et al. Among authors: ballantyne cm. World J Surg. 2007 Apr;31(4):676-81. doi: 10.1007/s00268-006-0712-2. World J Surg. 2007. PMID: 17387551 Review.

9

Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery.

Virani SS, Nambi V, Razavi M, Lee VV, Elayda M, Wilson JM, Ballantyne CM. Virani SS, et al. Among authors: ballantyne cm. Am Heart J. 2008 Mar;155(3):541-6. doi: 10.1016/j.ahj.2007.10.027. Epub 2007 Dec 19. Am Heart J. 2008. PMID: 18294494

10

Does preoperative statin therapy improve outcomes in patients undergoing isolated cardiac valve surgery?

Virani SS, Nambi V, Lee VV, Elayda M, Reul RM, Wilson JM, Ballantyne CM. Virani SS, et al. Among authors: ballantyne cm. Am J Cardiol. 2008 Nov 1;102(9):1235-9. doi: 10.1016/j.amjcard.2008.06.055. Epub 2008 Aug 27. Am J Cardiol. 2008. PMID: 18940299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,015 results

Search Page